GBT021601
Global Blood Therapeutics
[]
$gbt gbt presents positive new real-world evidence data at eha2022 congress further supporting clinical use of oxbryta (voxelotor) in sickle cell disease 
Free Stock Market News are delayed 15 sec. Full features and live news available here: https://t.co/fWRacb3Vft